Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

029 Group SE AGM Information 2006

Jun 15, 2006

4544_rns_2006-06-15_bbe3bf6a-769f-4586-8b80-f8795174544c.html

AGM Information

Open in viewer

Opens in your device viewer

News Details

Ad-hoc | 15 June 2006 13:42

Rhein Biotech N.V.: Annual General Meeting 2006

Ad hoc announcement transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. —————————————————————————— Ad-Hoc-Announcement Rhein Biotech N.V., WKN: 919 544, Geregelter Markt: RBO Annual General Meeting 2006 Maastricht, June 15, 2005 Rhein Biotech N.V. today held its annual general meeting of shareholders. All resolutions were adopted in accordance with the proposals in the published agenda. The minutes will be posted on the company’s website (www.rheinbiotech.com) in due course. For further information please contact: Harry Suykerbuyk Director Investor Relations and Corporate Communications Tel. +31-(0)71-524 8718 [email protected] (c)DGAP 15.06.2006 ————————————————————————— Language: English Issuer: Rhein Biotech N.V. Oude Maasstraat 47 6229 BC Maastricht Niederlande Phone: +31 433 56 78 9-0 Fax: +31 433 56 78 9-9 email: [email protected] WWW: www.bernabiotech.com ISIN: NL0000230324 WKN: 919544 indices: Listed: Geregelter Markt in Frankfurt (General Standard); Freiverkehr in Berlin-Bremen, Stuttgart, München, Hamburg, Düsseldorf End of News DGAP News-Service ————————————————————————